CoChat

Co-morbidity in rheumatoid arthritis

Mikuls, Ted R · 2003 · Best Practice & Research Clinical Rheumatology

The DOI matches its Crossref record; 175 of the 176 references it cites were found in a registry or an index.

Abstract

Rheumatoid arthritis (RA) affects approximately 0.5-1% of the population and imposes substantial societal costs including an increased risk of work-related disability and accelerated mortality. It is increasingly clear that RA-related co-morbidities, including cardiovascular disease (CVD), infection, osteoporosis, lymphoproliferative malignancy, and peptic ulcer disease, serve as major determinants of disease-associated outcome. In this review, the impact of these select co-morbidities on RA outcome is discussed. In addition, this review explores potential mechanisms underlying their association with RA, the possible iatrogenic role of agents used to treat the disease, and measures aimed at both prevention and treatment of disease-specific co-morbidity.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1521-6942(03)00041-x

Cites

175 of 175 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 175 references

Research works printed but not linked: 6

  1. Gabriel, 1999, Comorbidity in arthritis, Journal of Rheumatology, 26, 2475
  2. del Rincon, 1999, High incidence of cardiovascular events in rheumatoid arthritis cohort not explained by traditional cardiac risk factors, Arthritis & Rheumatism, 43, S1910
  3. Mikuls, 2000, The changing face of rheumatoid arthritis therapy: results of serial surveys, Arthritis & Rheumatism, 43, 464, 10.1002/1529-0131(200002)43:2<464::aid-anr30>3.0.co;2-u · doi:10.1002/1529-0131(200002)43:2<464::aid-anr30>3.0.co;2-u
  4. Safety update on TNF-α antagonists: infliximab and etanercept. Vol. 2002: US Food and Drug Administration.
  5. Edwards, 2002, Efficacy and safety of rituximab, a B-cell targeted chimeric monoclonal antibody: a randomized, placebo-controlled trial in patients with rheumatoid arthritis, Arthritis & Rheumatism, 46, s446
  6. Silverman, 1993, Quality of life after osteoporotic vertebral fracture, Arthritis & Rheumatism, 36, s122

Cited by

See all 136

Metadata

Authors
Mikuls, T. R.
Affiliations
Omaha VA Medical Center (US)
Corresponding author
Mikuls, Ted R
Venue
Best Practice & Research Clinical Rheumatology
Publisher
Elsevier BV
Published
2003-10
Volume
17
Issue
5
Pages
729-752
ISSN
1521-6942 (ISSN-L)
OpenAlex
W2072701586
Cited by
122
References
176
Citations by year
2026: 1 · 2025: 3 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 4 · 2020: 10 · 2019: 2 · 2018: 6 · 2017: 8 · 2016: 3 · 2015: 3 · 2014: 2 · 2013: 5 · 2012: 8
FWCI
0.90
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Best Practice & Research Clinical Rheumatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
  • Health Sciences › Medicine › Hematology › Autoimmune and Inflammatory Disorders Research
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Keywords
rheumatoid arthritis, comorbidities, cardiovascular disease, infection, osteoporosis, lymphoproliferative malignancies, peptic ulcer, disease outcome, comorbidity prevention
MeSH terms
Arthritis, Rheumatoid, Cardiovascular Diseases, Gastrointestinal Diseases, Humans, Infections, Neoplasms, Osteoporosis, Comorbidity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Co-morbidity in rheumatoid arthritis. https://app.cochat.ai/papers/10.1016/s1521-6942(03)00041-x
The paper
Mikuls, T. R. (2003). Co-morbidity in rheumatoid arthritis. Best Practice & Research Clinical Rheumatology. https://doi.org/10.1016/s1521-6942(03)00041-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.